Lung disease is the major cause of morbidity and mortality in cystic fibrosis, an autosomal recessive disease caused by mutations in CFTR. In cystic fibrosis, chronic infection and dysregulated neutrophilic inflammation lead to progressive airway destruction. The severity of cystic fibrosis lung disease has considerable heritability, independent of CFTR genotype1. To identify genetic modifiers, here we performed a genome-wide single nucleotide polymorphism scan in one cohort of cystic fibrosis patients, replicating top candidates in an independent cohort. This approach identified IFRD1 as a modifier of cystic fibrosis lung disease severity. IFRD1 is a histone-deacetylase-dependent transcriptional co-regulator expressed during terminal neutrophil differentiation. Neutrophils, but not macrophages, from Ifrd1-deficient mice showed blunted effector function, associated with decreased NF-κB p65 transactivation. In vivo, IFRD1 deficiency caused delayed bacterial clearance from the airway, but also less inflammation and disease—a phenotype primarily dependent on haematopoietic cell expression, or lack of expression, of IFRD1. In humans, IFRD1 polymorphisms were significantly associated with variation in neutrophil effector function. These data indicate that IFRD1 modulates the pathogenesis of cystic fibrosis lung disease through the regulation of neutrophil effector function.
Subscribe to Journal
Get full journal access for 1 year
only $3.90 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Vanscoy, L. L. et al. Heritability of lung disease severity in cystic fibrosis. Am. J. Respir. Crit. Care Med. 175, 1036–1043 (2007)
Welsh, M. J. et al. in Metabolic and Molecular Basis of Inherited Disease (eds Scriver, C. R., et al.) 5121–5188 (McGraw-Hill, 2001)
Muhlebach, M. S. & Noah, T. L. Endotoxin activity and inflammatory markers in the airways of young patients with cystic fibrosis. Am. J. Respir. Crit. Care Med. 165, 911–915 (2002)
Karp, C. L. et al. Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airway. Nature Immunol. 5, 388–392 (2004)
Drumm, M. L. et al. Genetic modifiers of lung disease in cystic fibrosis. N. Engl. J. Med. 353, 1443–1453 (2005)
Schluchter, M. D. et al. Classifying severity of cystic fibrosis lung disease using longitudinal pulmonary function data. Am. J. Respir. Crit. Care Med. 174, 780–786 (2006)
Kurukulaaratchy, R. J. et al. Characterisation of atopic and non-atopic wheeze in 10 year old children. Thorax 59, 563–568 (2004)
Abecasis, G. R. et al. Merlin–rapid analysis of dense genetic maps using sparse gene flow trees. Nature Genet. 30, 97–101 (2002)
Vietor, I. et al. TIS7 interacts with the mammalian SIN3 histone deacetylase complex in epithelial cells. EMBO J. 21, 4621–4631 (2002)
Vietor, I. & Huber, L. A. Role of TIS7 family of transcriptional regulators in differentiation and regeneration. Differentiation 75, 891–897 (2007)
GNF SymAtlas. 〈http://symatlas.gnf.org/SymAtlas〉 (2008)
Theilgaard-Monch, K. et al. The transcriptional program of terminal granulocytic differentiation. Blood 105, 1785–1796 (2005)
Vadivelu, S. K. et al. Muscle regeneration and myogenic differentiation defects in mice lacking TIS7. Mol. Cell. Biol. 24, 3514–3525 (2004)
Anrather, J. et al. NF-κB regulates phagocytic NADPH oxidase by inducing the expression of gp91 phox . J. Biol. Chem. 281, 5657–5667 (2006)
Riedemann, N. C. et al. Regulation by C5a of neutrophil activation during sepsis. Immunity 19, 193–202 (2003)
Donnelly, P. Progress and challenges in genome-wide association studies in humans. Nature 456, 728–731 (2008)
Rogers, C. S. et al. Disruption of the CFTR gene produces a model of cystic fibrosis in newborn pigs. Science 321, 1837–1841 (2008)
Martis, P. C. et al. C/EBPα is required for lung maturation at birth. Development 133, 1155–1164 (2006)
Mullins, D. N. et al. CEBPG transcription factor correlates with antioxidant and DNA repair genes in normal bronchial epithelial cells but not in individuals with bronchogenic carcinoma. BMC Cancer 5, 141 (2005)
Zhang, D. E. et al. Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein α-deficient mice. Proc. Natl Acad. Sci. USA 94, 569–574 (1997)
Bjerregaard, M. D. et al. The in vivo profile of transcription factors during neutrophil differentiation in human bone marrow. Blood 101, 4322–4332 (2003)
Wigginton, J. E. & Abecasis, G. R. PEDSTATS: descriptive statistics, graphics and quality assessment for gene mapping data. Bioinformatics 21, 3445–3447 (2005)
Abecasis, G. R. et al. A general test of association for quantitative traits in nuclear families. Am. J. Hum. Genet. 66, 279–292 (2000)
Divanovic, S. et al. Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105. Nature Immunol. 6, 571–578 (2005)
Richardson, M. P. et al. A simple flow cytometry assay using dihydrorhodamine for the measurement of the neutrophil respiratory burst in whole blood: comparison with the quantitative nitrobluetetrazolium test. J. Immunol. Methods 219, 187–193 (1998)
Atabani, S. F. et al. Natural measles causes prolonged suppression of interleukin-12 production. J. Infect. Dis. 184, 1–9 (2001)
Ellson, C. D. et al. Neutrophils from p40phox-/- mice exhibit severe defects in NADPH oxidase regulation and oxidant-dependent bacterial killing. J. Exp. Med. 203, 1927–1937 (2006)
Filippi, M. D. et al. Localization of Rac2 via the C terminus and aspartic acid 150 specifies superoxide generation, actin polarity and chemotaxis in neutrophils. Nature Immunol. 5, 744–751 (2004)
Finkelman, F. D. & Morris, S. C. Development of an assay to measure in vivo cytokine production in the mouse. Int. Immunol. 11, 1811–1818 (1999)
de Bakker, P. I. et al. Transferability of tag SNPs in genetic association studies in multiple populations. Nature Genet. 38, 1298–1303 (2006)
Yang, H. C. et al. New adjustment factors and sample size calculation in a DNA-pooling experiment with preferential amplification. Genetics 169, 399–410 (2005)
Hillian, A. D. et al. Modulation of cystic fibrosis lung disease by variants in interleukin-8. Genes Immun. 9, 501–508 (2008)
Devlin, B. et al. Unbiased methods for population-based association studies. Genet. Epidemiol. 21, 273–284 (2001)
Marchini, J. et al. A new multipoint method for genome-wide association studies by imputation of genotypes. Nature Genet. 39, 906–913 (2007)
Gronert, K. et al. in Methods in Molecular Biology Vol. 120 (ed Lianos, E. A.) 119–144 (Humana Press, 1999)
This work was funded by grants from the National Cystic Fibrosis Foundation (C.L.K., M.L.D., G.R.C. and M.R.K.), the National Heart Lung and Blood Institute (G.R.C., M.R.K. and C.L.K.), the Wake Forest University Health Sciences Center for Public Health Genomics (C.D.L. and A.H.W.) and the Austrian Science Fund (I.V. and L.A.H). We thank R. Pace and J. Yeatts for technical assistance, and D. Hassett for the P. aeruginosa FRD1 strain.
J.B.H. and J.R.K. hold equity interest in and receive consulting income from JK Autoimmunity Inc.
About this article
Cite this article
Gu, Y., Harley, I., Henderson, L. et al. Identification of IFRD1 as a modifier gene for cystic fibrosis lung disease. Nature 458, 1039–1042 (2009). https://doi.org/10.1038/nature07811
European Journal of Human Genetics (2021)
Carvacrol, Thymol, and Garlic Essential Oil Promote Skin Innate Immunity in Gilthead Seabream (Sparus aurata) Through the Multifactorial Modulation of the Secretory Pathway and Enhancement of Mucus Protective Capacity
Frontiers in Immunology (2021)
Significance of hub genes and immune cell infiltration identified by bioinformatics analysis in pelvic organ prolapse
Molecular Immunology (2020)